190 related articles for article (PubMed ID: 17420283)
21. Receptor profiling and endocrine interactions of tibolone.
de Gooyer ME; Deckers GH; Schoonen WG; Verheul HA; Kloosterboer HJ
Steroids; 2003 Jan; 68(1):21-30. PubMed ID: 12475720
[TBL] [Abstract][Full Text] [Related]
22. The need for tissue selective menopausal agents.
Eden J
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
[TBL] [Abstract][Full Text] [Related]
23. Regulation of SULT1E1 expression in Ishikawa adenocarcinoma cells by tibolone.
Falany JL; Falany CN
Steroids; 2006 Oct; 71(10):880-5. PubMed ID: 16857224
[TBL] [Abstract][Full Text] [Related]
24. Effects of long-term hormone treatment and of tibolone on monoamines and monoamine metabolites in the brains of ovariectomised, Cynomologous monkeys.
Gibbs RB; Edwards D; Lazar N; Nelson D; Talameh J
J Neuroendocrinol; 2006 Sep; 18(9):643-54. PubMed ID: 16879163
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of exogenous sex steroids and effect on brain functions with a focus on tibolone.
Verheul HA; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):195-204. PubMed ID: 17113982
[TBL] [Abstract][Full Text] [Related]
26. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
27. Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily.
Steckelbroeck S; Oyesanmi B; Jin Y; Lee SH; Kloosterboer HJ; Penning TM
J Pharmacol Exp Ther; 2006 Mar; 316(3):1300-9. PubMed ID: 16339391
[TBL] [Abstract][Full Text] [Related]
28. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF
J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
[TBL] [Abstract][Full Text] [Related]
29. Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: Evidence of progestogenic effects.
Schatz F; Kuczynski E; Kloosterboer HJ; Buchwalder L; Tang C; Krikun G; Lockwood CJ
Steroids; 2005 Nov; 70(12):840-5. PubMed ID: 16011840
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of tibolone in early and late postmenopausal women.
Timmer CJ; Verheul HA; Doorstam DP
Br J Clin Pharmacol; 2002 Aug; 54(2):101-6. PubMed ID: 12207627
[TBL] [Abstract][Full Text] [Related]
31. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
[TBL] [Abstract][Full Text] [Related]
32. Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone.
Maran A; Shogren K; Zhang M; Yaszemski MJ; Hefferan TE; Spelsberg TC; Kloosterboer HJ; Turner RT
Bone; 2006 Sep; 39(3):523-9. PubMed ID: 16707283
[TBL] [Abstract][Full Text] [Related]
33. Effects of tibolone on estrogen biosynthesis in the mammary tissue of postmenopausal monkeys.
Stute P; Register TC; Blair RM; Cline JM
Menopause; 2006; 13(2):232-40. PubMed ID: 16645537
[TBL] [Abstract][Full Text] [Related]
34. Tibolone and metabolites induce prolactin production in human endometrial stromal cells in vitro: evidence for cell-specific metabolism.
Groothuis PG; De Gooyer ME; ten Kate J; Menheere PP; Dunselman GA; de Goeij AF; Verbost P; Ederveen AG; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):152-60. PubMed ID: 16781141
[TBL] [Abstract][Full Text] [Related]
35. Dose proportionality of three different doses of tibolone.
Timmer CJ; Houwing NS
Pharmacotherapy; 2002 Jan; 22(1):6-13. PubMed ID: 11794431
[TBL] [Abstract][Full Text] [Related]
36. The in vivo human metabolism of tibolone.
Vos RM; Krebbers SF; Verhoeven CH; Delbressine LP
Drug Metab Dispos; 2002 Feb; 30(2):106-12. PubMed ID: 11792677
[TBL] [Abstract][Full Text] [Related]
37. The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites.
Raobaikady B; Day JM; Purohit A; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):229-37. PubMed ID: 15862970
[TBL] [Abstract][Full Text] [Related]
38. Effects of tibolone on sulfatase pathway of estrogens metabolism and on growth of MCF-7 human breast tumors implanted in ovariectomized nude mice.
Desreux J; Kloosterboer H; Noël A; Frankenne F; Lemaire M; Putman M; Foidart JM
Gynecol Obstet Invest; 2007; 63(1):31-8. PubMed ID: 16899995
[TBL] [Abstract][Full Text] [Related]
39. Determination of 3-α-hydroxytibolone in human plasma by LC-MS/MS: application for a pharmacokinetic study after administration of a tibolone formulation.
de Santana e Silva Cardoso FF; César IC; Mundim IM; de Souza Teixeira L; da Silva EP; Bonfim RR; Gomes SA; Ferreira DP; Lopes AR; Pascoal HD; de Souza WC; Pianetti GA
Biomed Chromatogr; 2013 Nov; 27(11):1457-62. PubMed ID: 23813413
[TBL] [Abstract][Full Text] [Related]
40. Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro.
Vanhoecke BW; Bracke ME; Kloosterboer HJ; Depypere HT
Maturitas; 2006 Jun; 54(3):229-37. PubMed ID: 16581209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
